Mycobacteria Infection in Incomplete Transverse Myelitis Is Refractory to Steroids: A Pilot Study
Author Information
Author(s): Feng Yanqing, Guo Ning, Liu Junxiu, Chen Xi, Sun Qiaosong, Lai Rong, Huang Fan
Primary Institution: The First Affiliated Hospital of Sun Yat-sen University
Hypothesis
Can antituberculous treatment help patients with incomplete transverse myelitis whose condition deteriorates despite steroid treatment?
Conclusion
Antituberculous treatment shows significant clinical benefits for patients with steroid-refractory incomplete transverse myelitis.
Supporting Evidence
- 49 out of 51 patients showed significant improvement in neurological signs after 24 months of treatment.
- Patients experienced increased scores on the American Spinal Injury Association and Barthel Index assessments.
- 16 patients withdrew from the study, primarily due to side effects or perceived lack of efficacy.
Takeaway
This study found that a special medicine for tuberculosis can help people with a serious spinal cord problem when other treatments don't work.
Methodology
This was a prospective, open-label study assessing the efficacy of antituberculous treatment in patients with steroid-refractory incomplete transverse myelitis over 24 months.
Potential Biases
Potential biases due to the open-label design and lack of a control group.
Limitations
The study was uncontrolled and had a small sample size.
Participant Demographics
The study included 67 patients, with 24 males and 43 females, and a median age of 39.07 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website